Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why Moderna Shares Are Rising Again Today

Moderna Inc (NASDAQ: MRNA) shares are trading higher by 8.5% to $214.34 on continued upward momentum after the company and Merck announced mRNA-4157/V940 in combination with KEYTRUDA, met the primary efficacy endpoint in the Phase 2b KEYNOTE-942 trial.
byHenry Khederian
December 14, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Moderna Inc (NASDAQ:MRNA) shares are trading higher by 8.5% to $214.34 on continued upward momentum after the company and Merck announced mRNA-4157/V940 in combination with KEYTRUDA, met the primary efficacy endpoint in the Phase 2b KEYNOTE-942 trial.

The results showed that mRNA cancer vaccine + Keytruda demonstrated a statistically significant and clinically meaningful improvement in recurrence-free survival (RFS) versus Keytruda alone for the adjuvant treatment of stage III/IV melanoma following complete resection…Read More

See Also: Moderna Soars On Cancer Vaccine News: Here’s What To Watch Going Forward

According to data from Benzinga Pro, MRNA has a 52-week high of $321.30 and a 52-week low of $115.03.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With AMC Entertainment Stock Today?

By Erica Kollmann
April 19, 12:34 PM
Retail investors have reignited interest in AMC, and the stock is frequently trending and moving on heavy trading volume. According to data from Benzinga Pro, more than 12.22 million shares have already been traded in Friday's session, on track to surpass the stock's 100-day average of 14.907 million shares.

AMC